Absorption characteristics of compounds with different molecular weights after application to the unilateral kidney surface in rats

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 58, Issue 3, 2004, Pages 705-711

  Nishida, Koyo ^a   Tomiyama, Naoki ^a   Mukai, Takahiro ^a   Nakashima, Mikiro ^b   Sasaki, Hitoshi ^b   Nakamura, Junzo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Absorption; Kidney surface; Molecular weight; Pharmacokinetics; Rat; Targeting

Indexed keywords

BROMOPHENOL BLUE; BROMSULFOPHTHALEIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; PHENOLSULFONPHTHALEIN;

AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CALCULATION; DIFFUSION; DRUG ABSORPTION; KIDNEY; KINETICS; MALE; MOLECULAR WEIGHT; NONHUMAN; RAT;

ABSORPTION; ADMINISTRATION, TOPICAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAVENOUS; JUGULAR VEINS; KIDNEY; MALE; MOLECULAR WEIGHT; PHARMACEUTICAL PREPARATIONS; PHENOLSULFONPHTHALEIN; RATS; RATS, WISTAR; SULFOBROMOPHTHALEIN; SURFACE PROPERTIES;

EID: 4644262706     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.04.016     Document Type: Article

References (32)

1. Noda S., Konno S., Tanaka J., Yamada M., Yoshitake N. Treatment of renal cell carcinoma with intra-arterial administration of SMANCS dissolved in Lipiodol. Anticancer Res. 10:1990;709-715
2. Kobayashi M., Imai K., Sugihara S., Maeda H., Konno T., Yamanaka H. Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma. Urology. 37:1991;288-294
3. Kato T., Nemoto R., Mori H., Takahashi M., Tamakawa Y. Transcatheter arterial chemoembolization of renal cell carcinoma with microencapsulated mitomycin C. J. Urol. 125:1981;19-24
4. Kato T., Sato K., Sasaki R., Kakinuma H., Moriyama M. Targeted cancer chemotherapy with arterial microcapsule chemoembolization: review of 1013 patients. Cancer Chemother. Pharmacol. 37:1996;289-296
5. Kerr D.J., Willmott N., McKillop J.H., Cummings J., Lewi H.J., McArdle C.S. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration. Cancer. 62:1988;878-883
6. McArdle C.S., Lewi H., Hansell D., Kerr D.J., McKillop J., Willmott N. Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapy. Br. J. Surg. 75:1988;132-134
7. Kawakami S., Horimoto T., Nishida K., Hirayama R., Mukai T., Nakashima M., Sasaki H., Sakaeda T., Nakamura J. Kidney- and site-selective delivery of 5-fluorouracil utilizing the absorption on the kidney surface in rats. Biol. Pharm. Bull. 25:2002;928-930
8. Nishida K., Sato N., Sasaki H., Nakamura J. Absorption of organic anions as model drugs following application to rat liver surface in-vivo. J. Pharm. Pharmacol. 46:1994;867-870
9. Nishida K., Sato N., Sasaki H., Nakamura J. Mechanism for drug absorption from rat-liver surface membrane: effect of dose and transport inhibitors on the pharmacokinetics of phenol red. J. Pharm. Pharmacol. 47:1995;227-231
10. Nishida K., Sato N., Sasaki H., Nakamura J. Effect of albumin on the absorption of phenol red, bromphenol blue and bromosulphonphthalein as model drugs from the liver surface membrane in rats. Biol. Pharm. Bull. 18:1995;1548-1550
11. Nishida K., Sato N., Nakakoga Y., Mukai T., Sasaki H., Nakamura J. Effect of application volume and area on the absorption of phenol red, as a model drug, from the liver surface in rats. J. Pharm. Pharmacol. 49:1997;976-980
12. Flessner M.F., Dedrick R.L., Schultz J.S. Exchange of macromolecules between peritoneal cavity and plasma. Am. J. Physiol. 248:1985;H15-H25
13. Leypoldt J.K., Parker H.R., Frigon R.P., Henderson L.W. Molecular size dependence of peritoneal transport. J. Lab. Clin. Med. 110:1987;207-216
14. Nagy J.A., Herzberg K.T., Masse E.M., Zientara G.P., Dvorak H.F. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res. 49:1989;5448-5458
15. w) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J. Biomed. Mater. Res. 21:1987;1341-1358
16. Yamamura Y., Santa T., Kotaki H., Uchino K., Sawada Y., Iga T. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability. Biol. Pharm. Bull. 18:1995;337-341
17. Nishida K., Sato N., Sasaki H., Nakamura J. Absorption characteristics of dextrans with different molecular weights from the liver surface membrane in rats: implications for targeting to the liver. J. Drug Target. 4:1996;141-150
18. Flessner M.F., Dedrick R.L., Reynolds J.C. Bidirectional peritoneal transport of immunoglobulin in rats: compartmental kinetics. Am. J. Physiol. 262:1992;F275-F287
19. Seymour L.W., Duncan R., Chytry V., Strohalm J., Ulbrich K., Kopecek J. Intraperitoneal and subcutaneous retention of a soluble polymeric drug-carrier bearing galactose. J. Control. Release. 16:1991;255-262
20. Hart L.G., Schanker L.S. The chemical forms in which phenol red is secreted into the bile of rats. Proc. Soc. Exp. Biol. Med. 123:1966;433-435
21. Takada K., Narumiya O., Muranishi S. Biopharmaceutical study of the hepato-biliary transport of drugs. III. Binding characteristics of bromphenol blue and amaranth to the liver cytoplasmic Y and Z binding proteins in vitro. Chem. Pharm. Bull. 23:1975;729-735
22. Baker K.J., Bradley S.E. Binding of sulfobromophthalein (BSP) sodium by plasma albumin. Its role in hepatic BSP extraction. J. Clin. Invest. 45:1966;281-287
23. Yamaoka K., Nakagawa T., Uno T. Statistical moments in pharmacokinetics. J. Pharmacokinet. Biopharm. 6:1978;547-558
24. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4:1981;879-885
25. Nishida K., Tonegawa C., Nakane S., Takakura Y., Hashida M., Sezaki H. Effect of electric charge on the hepatic uptake of macromolecules in the rat liver. Int. J. Pharm. 65:1990;7-17
26. Nishida K., Mihara K., Takino T., Nakane S., Takakura Y., Hashida M., Sezaki H. Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver. Pharm. Res. 8:1991;437-444
27. Mehvar R., Shepard T.L. Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. J. Pharm. Sci. 81:1992;908-912
28. Mehvar R., Robinson M.A., Reynolds J.M. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. J. Pharm. Sci. 83:1994;1495-1499
29. Koizumi T., Arita T., Kakemi K. Absorption and excretion of drugs. XIX. Some pharmacokinetic aspects of absorption and excretion of sulfonamides. 1. Absorption from rat stomach. Chem. Pharm. Bull. 12:1964;413-420
30. Koizumi T., Arita T., Kakemi K. Absorption and excretion of drugs. XX. Some pharmacokinetic aspects of absorption and excretion of sulfonamide. 2. Absorption from rat small intestine. Chem. Pharm. Bull. 12:1964;421-427
31. Hirszel P., Chakrabarti E.K., Bennett R.R., Maher J.F. Permselectivity of the peritoneum to neutral dextrans. Trans. Am. Soc. Artif. Intern. Organs. 30:1984;625-629
32. Dedrick R.L., Flessner M.F. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J. Natl Cancer Inst. 89:1997;480-487